Lonza Moda Solution Overview 2010 Final 18 Aug2010
•
3 likes•1,096 views
The document describes Lonza's MODA solution for automating quality control processes. Key features of the MODA solution include making the quality control workflow entirely paperless, utilizing mobile devices and RFID technology to automate data capture, and providing on-demand reporting and analytics. The MODA solution is estimated to provide tangible benefits like cost reduction, improved productivity, and enhanced compliance through error reduction and faster data access. A demonstration of the MODA solution's mobile data collection capabilities and paperless quality control workflow is also included.
Report
Share
Report
Share
![Agenda ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommended
منهج الحساب لثانية حضانة الترم الأول 2015
بوكلت شرح منهج الحساب والمهارات الرياضية لثانية حضانة واختبارات وتدريبات
بوكلت تدريبات اللغة العربية للصف الأول الابتدائى الجديد للترم الأول 2016 أمني...
بوكلت تدريبات منهج العربى أولى ابتدائى للترم الأول
بوكلت اللغة العربية والمهارات اللغوية لأولى حضانة ترم أول 2015
بوكلت اللغة العربية والمهارات اللغوية أولى حضانة 2015 ترم أول
بوكلت المهارات الرياضية لأولى حضانة ترم أول 2015
بوكلت الحساب والمهارات الرياضية لأولى حضانة الترم الأول 2015
تصميم المقررات الالكترونية
يمثل التعليم الالكتروني صناعة العصر الحديث لما يمثله من نقلة نوعية في مجال التعليم ووسيلة فاعلة لحل الكثير من مشكلاته المتراكمة على مر السنوات الماضية إلا أن الدخول في معترك التعليم الالكتروني يواجه الكثير من التحديات واهم هذه التحديات هي إنتاج المحتوى الالكتروني للمقررات طبقاً لمعايير الجودة مع احترام حقوق الملكية الفكرية للغير.
ملزمة لغتي للصف الأول الأبتدائي الفصل الثاني
ملزمة الفصل الدراسي الثاني لغتي تشمل التدريب على القرآءة والكتابة والإملاء والتقويم
Arabic Origin of Medical Terms الجذور العربية في المصطلحات الطبية
يتناول هذا الكتاب المصطلحات الطبية العربية المنشأ والتى تزدان بها المعاجم الأجنبية، حيث تم استعراض ذلك بصورة منهجية ومتدرجة, استهلالاً بالمصطلحات التي أقر بعروبتها واضعو المعاجم الأجنبية ومرورا بما سردته بعض الدراسات العربية من مصطلحات ذات أصول عربية وانتهاء بالقائمة الرئيسة, والتى قمت خلالها ببيان الدلائل اللغوية والطبية التى تثبت عربية العشرات من المصطلحات التى لم يتم التطرق إليها أو الكشف عنها من قبل – فيما أحسب.
Recommended
منهج الحساب لثانية حضانة الترم الأول 2015
بوكلت شرح منهج الحساب والمهارات الرياضية لثانية حضانة واختبارات وتدريبات
بوكلت تدريبات اللغة العربية للصف الأول الابتدائى الجديد للترم الأول 2016 أمني...
بوكلت تدريبات منهج العربى أولى ابتدائى للترم الأول
بوكلت اللغة العربية والمهارات اللغوية لأولى حضانة ترم أول 2015
بوكلت اللغة العربية والمهارات اللغوية أولى حضانة 2015 ترم أول
بوكلت المهارات الرياضية لأولى حضانة ترم أول 2015
بوكلت الحساب والمهارات الرياضية لأولى حضانة الترم الأول 2015
تصميم المقررات الالكترونية
يمثل التعليم الالكتروني صناعة العصر الحديث لما يمثله من نقلة نوعية في مجال التعليم ووسيلة فاعلة لحل الكثير من مشكلاته المتراكمة على مر السنوات الماضية إلا أن الدخول في معترك التعليم الالكتروني يواجه الكثير من التحديات واهم هذه التحديات هي إنتاج المحتوى الالكتروني للمقررات طبقاً لمعايير الجودة مع احترام حقوق الملكية الفكرية للغير.
ملزمة لغتي للصف الأول الأبتدائي الفصل الثاني
ملزمة الفصل الدراسي الثاني لغتي تشمل التدريب على القرآءة والكتابة والإملاء والتقويم
Arabic Origin of Medical Terms الجذور العربية في المصطلحات الطبية
يتناول هذا الكتاب المصطلحات الطبية العربية المنشأ والتى تزدان بها المعاجم الأجنبية، حيث تم استعراض ذلك بصورة منهجية ومتدرجة, استهلالاً بالمصطلحات التي أقر بعروبتها واضعو المعاجم الأجنبية ومرورا بما سردته بعض الدراسات العربية من مصطلحات ذات أصول عربية وانتهاء بالقائمة الرئيسة, والتى قمت خلالها ببيان الدلائل اللغوية والطبية التى تثبت عربية العشرات من المصطلحات التى لم يتم التطرق إليها أو الكشف عنها من قبل – فيما أحسب.
Hráefni jpa
This document discusses raw material collection for fishmeal factories in Iceland. It provides data on the amounts and sources of raw materials received by factories in 2014, including over 400,000 tons total with nearly half coming from discards. Recommendations for fish quotas in 2015 are presented, as well as projections for the amounts of fish that will be processed into fishmeal and fish oil in 2015, estimated at over 745,000 tons total with around 38% coming from discards. A list of 11 Icelandic fishmeal factories and their total processing capacities is also included.
Pagina 1 politica
Pedro Bial afirma que é obrigado a apresentar o Big Brother Brasil porque a Globo mantém sua família refém na Índia, onde eles são atração de um reality show chamado "A Família de um Idiota". Bial também diz que é forçado a usar os mesmos clichês há 15 anos no programa.
Pagina 1 politica
O documento propõe implantar um governo comunista radical que proíbe bebidas capitalistas como Coca-Cola e redistribui riquezas apenas para aqueles com camisas velhas de sindicatos. Os ricos seriam deportados para Cuba e substituídos por ativistas de esquerda das universidades, apesar da dependência contínua de marcas como McDonald's.
IMS Health Workshop World Orphan Drug Congress
This document provides an agenda for a workshop titled "Using real-world data to find undiagnosed patients with rare diseases" hosted by IMS Health at the World Orphan Drug Congress from April 20-22 in Washington D.C. The workshop will explore how real-world data can help address underdiagnosis of rare diseases. Speakers will discuss using large-scale real-world data to transform understanding of rare diseases, and present case studies of companies leveraging real-world data. The workshop will also cover using predictive modeling of real-world data to identify undiagnosed rare disease patients and new engagement models with healthcare providers and payers to increase rare disease treatments.
Big data e social media nel Pharma - IMS Health Italia @Aboutpharma Digital S...
Social media e Pharma sono inconciliabili?
Ne abbiamo parlato come keynote speaker al Digital Summit di Aboutpharma del'8 giugno 2016, dimostrando come un'azienda farmaceutica utilizzando gli strumenti giusti possa seguire tutto quanto è pubblicato online ed estrarre da questi big (real-world ) data tutto il valore.
How fit is your capital allocation strategy?
Summary: Even in a time of high biopharma valuations, adopting an activist mentality adds rigor to capital allocation and strategic decision-making, improving not just returns to shareholders but long-term value creation. Therefore, biopharma management teams and boards of directors should proactively assess the “fitness” of their capital allocation strategies and their alignment with operational performance goals by taking an outsider’s view of the business even when times are good — and before a material stumble provides a compelling reason for an outsider to act. For more on this topic, go to http://www.ey.com/GL/en/Industries/Life-Sciences/EY-vital-signs-how-fit-is-your-capital-allocation-strategy.
Акция благотворительность вместо сувениров
Ежегодно российские компании тратят около 26 миллиардов рублей на сувениры. А рейтинг самых популярных подарков возглавляют алкоголь, канцелярские товары и сладости.
В 2007 году российским филиалом британского фонда Charities Aid Foundation был запущен проект «Благотворительность вместо сувениров».
Как проходит акция?
Несколько художников разрабатывают специально для фонда «Вера» красивые и жизнерадостные открытки в разных стилях. Компания перечисляет весь сувенирный бюджет или его часть на наши благотворительные программы. Взамен мы предлагаем на выбор открытки, которые можно подарить партнерам и коллегам вместо коробки конфет или какого-нибудь сувенира, который может никогда не пригодиться. На открытки компании могут нанести свой логотип и поздравления. Открыть и скачать Презентацию
Среди художников, которые предоставляют нам свои уникальные работы – Наталья Грофпель, Алексей Зуев, Елена Оберемок и другие.
Кому это может помочь?
Одна и та же «сувенирная» сумма способна стать бутылкой элитного шампанского или специальным лечебным питанием для малыша, которого кормят через гастростому. Деньги, потраченные на очередные коробки дорогих конфет, могли бы обеспечить пациента хосписа матрасом против пролежней.
Участвуя в акции, вы помогаете российским хосписам и их пациентам – неизлечимо больным детям и взрослым, а также содействуете образованию сотрудников хосписов и развитию волонтерского движения.
Какие результаты приносит акция?
С каждым годом в рамках акции удается собрать все больше средств для тех, кто нуждается в помощи. Например, в 2014 году в акции приняли участие 28 компаний и организаций, благодаря которым удалось собрать более 15 млн. рублей. А это в 7 раз больше, чем в 2013 году!
Среди организаций, в разное время участвовавших в акции — ГК «Ташир», Холдинг «Открытие», РусГидро, Тойота Банк, Делойт, Да Винчи Капитал, профсоюз Росимущества, Aviasales, Бинооптик, «ЮниКредит Банк», «Дойче Банк», «РосБанк», Триза-Консалтинг, Транскомплект и многие другие.
Фонд «Вера» участвует в проекте ежегодно – в преддверии Нового Года и 8 марта.
Как принять участие в акции?
В акции может принять участие любая организация, решившая полностью или частично на
Паллиативная помощь в Подмосковье
13 октября 2015 года на заседании правительства Московской области обсуждали организацию паллиативной помощи в Подмосковье. В частности – помощь в стационаре и на дому, вопросы лекарственного обеспечения и обезболивания.
Министр здравоохранения области Нина Владимировна Суслонова рассказала губернатору и слушателям о том, как обстоят дела сейчас, и о планах на ближайшие два года.
Важно понимать, что качественная паллиативная помощь – это не количество коек или объем доступных препаратов. Это знания и опыт врачей и медсестер, уважение к человеку, умение и готовность поддержать его близких.
И все же невероятно важно, что озвученные на заседании цифры фигурируют в планах и что бюджет на их реализацию согласован!
Держим пальцы, чтобы задуманное осуществилось. Огромное спасибо всем, кто этому содействует! В частности – губернатору области Андрею Юрьевичу Воробьеву и его заместителю Ольге Сергеевне Забраловой за внимание к теме паллиативной помощи.
Вместе с мамой. Что делать, когда твой ребенок в реанимации
Благотворительный фонд «Детский паллиатив» http://rcpcf.ru подготовил пособие «Вместе с мамой. Что делать, когда твой ребенок в реанимации». Авторы - мамы, которые на собственном опыте узнали, что такое детская реанимация. С другими родителями они делятся рекомендациями - как защитить свои права и права ребенка, избежав конфликта с сотрудниками больницы.
Honeywell User's Group Almirall's MES case study
The document discusses the implementation of a POMS MES system at Almirall, a pharmaceutical company. It describes how the MES system improved quality and production operations through integrated management of processes like purchasing, manufacturing, quality control and logistics. Key benefits included improved traceability, compliance and flexibility to remain competitive through continuous optimization of manufacturing execution.
BBI Solutions - Contract Services
An overview of BBI Solutions Contract Services for Lateral Flow Test Development and OEM Lateral Flow Test Manufacture.
BILS 2015 Umetrics Stefan Raennar
This document discusses how design of experiments (DOE) and multivariate data analysis (MVDA) using Umetrics software can help optimize biomanufacturing processes and ensure quality. DOE is used to build process understanding, identify critical parameters, and define a design space. MVDA condenses large process data sets into informative plots to improve process monitoring, control, and verification. Case studies from companies like Novartis, Biogen, and Lonza demonstrate benefits like increased yield, reduced risk, and improved root cause analysis through the use of DOE and MVDA tools.
JANELLE HEPPES RESUME
Janelle Heppes is seeking a position as a Quality Control Laboratory Supervisor. She has over 13 years of experience in this role at 3M, where she supervised chemists, led daily lab operations, and ensured on-time testing. Some of her accomplishments include receiving safety awards, product approvals from the FDA, cost savings initiatives, and process improvements. She is skilled in leadership, collaboration, execution, developing others, and acting with integrity.
Performance testing reference model
Presentation briefly summarizes typical performance tests and their applicability in software development life-cycle
Pilot plant & scale up techniques
This document discusses pilot plant design, operation, and scale up considerations for pharmaceutical manufacturing processes. It provides an overview of the need for pilot plants and scale up to transfer processes from the laboratory to production scale. Key sections include descriptions of pilot plant attributes, operational aspects like validation and training, scale up principles of similarity, and development milestones from formulation through clinical and commercial production. Process parameters that should be evaluated at various stages like mixing, drying, milling and compression are also outlined.
Part 10 lean operation in health industry
This document discusses lean principles and their application in healthcare. It provides background on Toyota and defines lean as eliminating waste from the customer's perspective. Key lean concepts are presented, like the Toyota Production System's four pillars. Examples show lean improving productivity, quality and throughput in healthcare. Various lean tools are explained for analyzing and improving processes, like value stream mapping, standard work, and performance metrics. The document concludes by outlining Toyota's 14 principles for a lean development process in healthcare.
An Enterprise Approach to Engine Test Analysis: Requirements for Implementation
Engine and vehicle OEMs have complex product development requirements that call for capable and standardized post-test analysis while simultaneously dealing with high levels of product technology and test diversity. Many organizations rely on shared spreadsheets or distributed desktop tools, which can produce inconsistent and non-traceable results.
This presentation addresses enterprise-scale post-processing requirements, features and implementation considerations in addition to providing lessons learned that can help move an organization to an efficient, standardized and maintainable professional process.
The presentation will cover how to address diversity of product topology, physical components, fluid properties, measurement uncertainty, naming conventions, traceability and IT architecture.
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Watch the presentation of this webinar here: https://bit.ly/3adaxWh
When implementing new automation systems, organizations must consider things like deployment time, user adoption, and costs.
They must also consider the cost of doing nothing – that is, what competitive advantage is lost in standing still? What time and quality is lost in repetitive, manual tasks rather than an automated, digital workflow? What operational efficiencies are lost?
In this webinar we examine how a product, process, and system agnostic automation platform can be deployed faster than traditional system specific software while bringing greater operational efficiencies (in many cases over 30% improvement).
To remain competitive in the market, biopharma manufacturers must adopt automation and digital technologies, but most plants still have island of automation consisting of independently functioning, standalone unit operations. This results in operational inefficiency, regulatory concerns, and a poor understanding of the process and product life cycle.
Taking the first, right step must include considering risks, costs, timelines, and technology alternatives. Traditional automation approaches tied to specific systems, processes, and products are, by their nature, limited; while an agnostic platform will address current biomanufacturing business challenges and ensure future readiness. With the right platform, a phased automation implementation can yield operational efficiency gains of up to 30% and improved product quality and regulatory compliance.
In this webinar, let's explore:
• Challenges of automation and digital technology adoption
• What a product, process, and system agnostic platform entails
• Applications and benefits of a process orchestration platform
• Ensuring future readiness with process orchestration
Presented by:
Braj Nandan Thakur, Global Product Manager - Automation
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Watch the presentation of this webinar here: https://bit.ly/3adaxWh
When implementing new automation systems, organizations must consider things like deployment time, user adoption, and costs.
They must also consider the cost of doing nothing – that is, what competitive advantage is lost in standing still? What time and quality is lost in repetitive, manual tasks rather than an automated, digital workflow? What operational efficiencies are lost?
In this webinar we examine how a product, process, and system agnostic automation platform can be deployed faster than traditional system specific software while bringing greater operational efficiencies (in many cases over 30% improvement).
To remain competitive in the market, biopharma manufacturers must adopt automation and digital technologies, but most plants still have island of automation consisting of independently functioning, standalone unit operations. This results in operational inefficiency, regulatory concerns, and a poor understanding of the process and product life cycle.
Taking the first, right step must include considering risks, costs, timelines, and technology alternatives. Traditional automation approaches tied to specific systems, processes, and products are, by their nature, limited; while an agnostic platform will address current biomanufacturing business challenges and ensure future readiness. With the right platform, a phased automation implementation can yield operational efficiency gains of up to 30% and improved product quality and regulatory compliance.
In this webinar, let's explore:
• Challenges of automation and digital technology adoption
• What a product, process, and system agnostic platform entails
• Applications and benefits of a process orchestration platform
• Ensuring future readiness with process orchestration
Presented by:
Braj Nandan Thakur, Global Product Manager - Automation
Full automation
Automation in clinical laboratories can help reduce errors, decrease turnaround times, and improve productivity. It is important to fully understand current laboratory processes and identify bottlenecks before implementing automation solutions. A successful automation project requires optimizing existing workflows, clear objectives, evaluation of alternatives, and consideration of all costs. Future laboratory automation may include more integrated systems, robotics, and artificial intelligence to further improve efficiency and quality of testing.
Processes and technology ppt @ DOMS
The document discusses various topics related to processes and technology in manufacturing:
- It outlines different types of manufacturing processes like project, batch, mass production, and continuous production.
- It covers process planning, analysis, selection, and innovation. Tools for process analysis like flowcharts and process maps are presented.
- Principles for redesigning processes through innovation are provided, along with techniques for generating innovative ideas.
- Components of e-manufacturing technology are reviewed, including CAD/CAM, CNC machines, and e-procurement.
More Related Content
Viewers also liked
Hráefni jpa
This document discusses raw material collection for fishmeal factories in Iceland. It provides data on the amounts and sources of raw materials received by factories in 2014, including over 400,000 tons total with nearly half coming from discards. Recommendations for fish quotas in 2015 are presented, as well as projections for the amounts of fish that will be processed into fishmeal and fish oil in 2015, estimated at over 745,000 tons total with around 38% coming from discards. A list of 11 Icelandic fishmeal factories and their total processing capacities is also included.
Pagina 1 politica
Pedro Bial afirma que é obrigado a apresentar o Big Brother Brasil porque a Globo mantém sua família refém na Índia, onde eles são atração de um reality show chamado "A Família de um Idiota". Bial também diz que é forçado a usar os mesmos clichês há 15 anos no programa.
Pagina 1 politica
O documento propõe implantar um governo comunista radical que proíbe bebidas capitalistas como Coca-Cola e redistribui riquezas apenas para aqueles com camisas velhas de sindicatos. Os ricos seriam deportados para Cuba e substituídos por ativistas de esquerda das universidades, apesar da dependência contínua de marcas como McDonald's.
IMS Health Workshop World Orphan Drug Congress
This document provides an agenda for a workshop titled "Using real-world data to find undiagnosed patients with rare diseases" hosted by IMS Health at the World Orphan Drug Congress from April 20-22 in Washington D.C. The workshop will explore how real-world data can help address underdiagnosis of rare diseases. Speakers will discuss using large-scale real-world data to transform understanding of rare diseases, and present case studies of companies leveraging real-world data. The workshop will also cover using predictive modeling of real-world data to identify undiagnosed rare disease patients and new engagement models with healthcare providers and payers to increase rare disease treatments.
Big data e social media nel Pharma - IMS Health Italia @Aboutpharma Digital S...
Social media e Pharma sono inconciliabili?
Ne abbiamo parlato come keynote speaker al Digital Summit di Aboutpharma del'8 giugno 2016, dimostrando come un'azienda farmaceutica utilizzando gli strumenti giusti possa seguire tutto quanto è pubblicato online ed estrarre da questi big (real-world ) data tutto il valore.
How fit is your capital allocation strategy?
Summary: Even in a time of high biopharma valuations, adopting an activist mentality adds rigor to capital allocation and strategic decision-making, improving not just returns to shareholders but long-term value creation. Therefore, biopharma management teams and boards of directors should proactively assess the “fitness” of their capital allocation strategies and their alignment with operational performance goals by taking an outsider’s view of the business even when times are good — and before a material stumble provides a compelling reason for an outsider to act. For more on this topic, go to http://www.ey.com/GL/en/Industries/Life-Sciences/EY-vital-signs-how-fit-is-your-capital-allocation-strategy.
Акция благотворительность вместо сувениров
Ежегодно российские компании тратят около 26 миллиардов рублей на сувениры. А рейтинг самых популярных подарков возглавляют алкоголь, канцелярские товары и сладости.
В 2007 году российским филиалом британского фонда Charities Aid Foundation был запущен проект «Благотворительность вместо сувениров».
Как проходит акция?
Несколько художников разрабатывают специально для фонда «Вера» красивые и жизнерадостные открытки в разных стилях. Компания перечисляет весь сувенирный бюджет или его часть на наши благотворительные программы. Взамен мы предлагаем на выбор открытки, которые можно подарить партнерам и коллегам вместо коробки конфет или какого-нибудь сувенира, который может никогда не пригодиться. На открытки компании могут нанести свой логотип и поздравления. Открыть и скачать Презентацию
Среди художников, которые предоставляют нам свои уникальные работы – Наталья Грофпель, Алексей Зуев, Елена Оберемок и другие.
Кому это может помочь?
Одна и та же «сувенирная» сумма способна стать бутылкой элитного шампанского или специальным лечебным питанием для малыша, которого кормят через гастростому. Деньги, потраченные на очередные коробки дорогих конфет, могли бы обеспечить пациента хосписа матрасом против пролежней.
Участвуя в акции, вы помогаете российским хосписам и их пациентам – неизлечимо больным детям и взрослым, а также содействуете образованию сотрудников хосписов и развитию волонтерского движения.
Какие результаты приносит акция?
С каждым годом в рамках акции удается собрать все больше средств для тех, кто нуждается в помощи. Например, в 2014 году в акции приняли участие 28 компаний и организаций, благодаря которым удалось собрать более 15 млн. рублей. А это в 7 раз больше, чем в 2013 году!
Среди организаций, в разное время участвовавших в акции — ГК «Ташир», Холдинг «Открытие», РусГидро, Тойота Банк, Делойт, Да Винчи Капитал, профсоюз Росимущества, Aviasales, Бинооптик, «ЮниКредит Банк», «Дойче Банк», «РосБанк», Триза-Консалтинг, Транскомплект и многие другие.
Фонд «Вера» участвует в проекте ежегодно – в преддверии Нового Года и 8 марта.
Как принять участие в акции?
В акции может принять участие любая организация, решившая полностью или частично на
Паллиативная помощь в Подмосковье
13 октября 2015 года на заседании правительства Московской области обсуждали организацию паллиативной помощи в Подмосковье. В частности – помощь в стационаре и на дому, вопросы лекарственного обеспечения и обезболивания.
Министр здравоохранения области Нина Владимировна Суслонова рассказала губернатору и слушателям о том, как обстоят дела сейчас, и о планах на ближайшие два года.
Важно понимать, что качественная паллиативная помощь – это не количество коек или объем доступных препаратов. Это знания и опыт врачей и медсестер, уважение к человеку, умение и готовность поддержать его близких.
И все же невероятно важно, что озвученные на заседании цифры фигурируют в планах и что бюджет на их реализацию согласован!
Держим пальцы, чтобы задуманное осуществилось. Огромное спасибо всем, кто этому содействует! В частности – губернатору области Андрею Юрьевичу Воробьеву и его заместителю Ольге Сергеевне Забраловой за внимание к теме паллиативной помощи.
Вместе с мамой. Что делать, когда твой ребенок в реанимации
Благотворительный фонд «Детский паллиатив» http://rcpcf.ru подготовил пособие «Вместе с мамой. Что делать, когда твой ребенок в реанимации». Авторы - мамы, которые на собственном опыте узнали, что такое детская реанимация. С другими родителями они делятся рекомендациями - как защитить свои права и права ребенка, избежав конфликта с сотрудниками больницы.
Viewers also liked (10)
Big data e social media nel Pharma - IMS Health Italia @Aboutpharma Digital S...
Big data e social media nel Pharma - IMS Health Italia @Aboutpharma Digital S...
Вместе с мамой. Что делать, когда твой ребенок в реанимации
Вместе с мамой. Что делать, когда твой ребенок в реанимации
Similar to Lonza Moda Solution Overview 2010 Final 18 Aug2010
Honeywell User's Group Almirall's MES case study
The document discusses the implementation of a POMS MES system at Almirall, a pharmaceutical company. It describes how the MES system improved quality and production operations through integrated management of processes like purchasing, manufacturing, quality control and logistics. Key benefits included improved traceability, compliance and flexibility to remain competitive through continuous optimization of manufacturing execution.
BBI Solutions - Contract Services
An overview of BBI Solutions Contract Services for Lateral Flow Test Development and OEM Lateral Flow Test Manufacture.
BILS 2015 Umetrics Stefan Raennar
This document discusses how design of experiments (DOE) and multivariate data analysis (MVDA) using Umetrics software can help optimize biomanufacturing processes and ensure quality. DOE is used to build process understanding, identify critical parameters, and define a design space. MVDA condenses large process data sets into informative plots to improve process monitoring, control, and verification. Case studies from companies like Novartis, Biogen, and Lonza demonstrate benefits like increased yield, reduced risk, and improved root cause analysis through the use of DOE and MVDA tools.
JANELLE HEPPES RESUME
Janelle Heppes is seeking a position as a Quality Control Laboratory Supervisor. She has over 13 years of experience in this role at 3M, where she supervised chemists, led daily lab operations, and ensured on-time testing. Some of her accomplishments include receiving safety awards, product approvals from the FDA, cost savings initiatives, and process improvements. She is skilled in leadership, collaboration, execution, developing others, and acting with integrity.
Performance testing reference model
Presentation briefly summarizes typical performance tests and their applicability in software development life-cycle
Pilot plant & scale up techniques
This document discusses pilot plant design, operation, and scale up considerations for pharmaceutical manufacturing processes. It provides an overview of the need for pilot plants and scale up to transfer processes from the laboratory to production scale. Key sections include descriptions of pilot plant attributes, operational aspects like validation and training, scale up principles of similarity, and development milestones from formulation through clinical and commercial production. Process parameters that should be evaluated at various stages like mixing, drying, milling and compression are also outlined.
Part 10 lean operation in health industry
This document discusses lean principles and their application in healthcare. It provides background on Toyota and defines lean as eliminating waste from the customer's perspective. Key lean concepts are presented, like the Toyota Production System's four pillars. Examples show lean improving productivity, quality and throughput in healthcare. Various lean tools are explained for analyzing and improving processes, like value stream mapping, standard work, and performance metrics. The document concludes by outlining Toyota's 14 principles for a lean development process in healthcare.
An Enterprise Approach to Engine Test Analysis: Requirements for Implementation
Engine and vehicle OEMs have complex product development requirements that call for capable and standardized post-test analysis while simultaneously dealing with high levels of product technology and test diversity. Many organizations rely on shared spreadsheets or distributed desktop tools, which can produce inconsistent and non-traceable results.
This presentation addresses enterprise-scale post-processing requirements, features and implementation considerations in addition to providing lessons learned that can help move an organization to an efficient, standardized and maintainable professional process.
The presentation will cover how to address diversity of product topology, physical components, fluid properties, measurement uncertainty, naming conventions, traceability and IT architecture.
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Watch the presentation of this webinar here: https://bit.ly/3adaxWh
When implementing new automation systems, organizations must consider things like deployment time, user adoption, and costs.
They must also consider the cost of doing nothing – that is, what competitive advantage is lost in standing still? What time and quality is lost in repetitive, manual tasks rather than an automated, digital workflow? What operational efficiencies are lost?
In this webinar we examine how a product, process, and system agnostic automation platform can be deployed faster than traditional system specific software while bringing greater operational efficiencies (in many cases over 30% improvement).
To remain competitive in the market, biopharma manufacturers must adopt automation and digital technologies, but most plants still have island of automation consisting of independently functioning, standalone unit operations. This results in operational inefficiency, regulatory concerns, and a poor understanding of the process and product life cycle.
Taking the first, right step must include considering risks, costs, timelines, and technology alternatives. Traditional automation approaches tied to specific systems, processes, and products are, by their nature, limited; while an agnostic platform will address current biomanufacturing business challenges and ensure future readiness. With the right platform, a phased automation implementation can yield operational efficiency gains of up to 30% and improved product quality and regulatory compliance.
In this webinar, let's explore:
• Challenges of automation and digital technology adoption
• What a product, process, and system agnostic platform entails
• Applications and benefits of a process orchestration platform
• Ensuring future readiness with process orchestration
Presented by:
Braj Nandan Thakur, Global Product Manager - Automation
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Watch the presentation of this webinar here: https://bit.ly/3adaxWh
When implementing new automation systems, organizations must consider things like deployment time, user adoption, and costs.
They must also consider the cost of doing nothing – that is, what competitive advantage is lost in standing still? What time and quality is lost in repetitive, manual tasks rather than an automated, digital workflow? What operational efficiencies are lost?
In this webinar we examine how a product, process, and system agnostic automation platform can be deployed faster than traditional system specific software while bringing greater operational efficiencies (in many cases over 30% improvement).
To remain competitive in the market, biopharma manufacturers must adopt automation and digital technologies, but most plants still have island of automation consisting of independently functioning, standalone unit operations. This results in operational inefficiency, regulatory concerns, and a poor understanding of the process and product life cycle.
Taking the first, right step must include considering risks, costs, timelines, and technology alternatives. Traditional automation approaches tied to specific systems, processes, and products are, by their nature, limited; while an agnostic platform will address current biomanufacturing business challenges and ensure future readiness. With the right platform, a phased automation implementation can yield operational efficiency gains of up to 30% and improved product quality and regulatory compliance.
In this webinar, let's explore:
• Challenges of automation and digital technology adoption
• What a product, process, and system agnostic platform entails
• Applications and benefits of a process orchestration platform
• Ensuring future readiness with process orchestration
Presented by:
Braj Nandan Thakur, Global Product Manager - Automation
Full automation
Automation in clinical laboratories can help reduce errors, decrease turnaround times, and improve productivity. It is important to fully understand current laboratory processes and identify bottlenecks before implementing automation solutions. A successful automation project requires optimizing existing workflows, clear objectives, evaluation of alternatives, and consideration of all costs. Future laboratory automation may include more integrated systems, robotics, and artificial intelligence to further improve efficiency and quality of testing.
Processes and technology ppt @ DOMS
The document discusses various topics related to processes and technology in manufacturing:
- It outlines different types of manufacturing processes like project, batch, mass production, and continuous production.
- It covers process planning, analysis, selection, and innovation. Tools for process analysis like flowcharts and process maps are presented.
- Principles for redesigning processes through innovation are provided, along with techniques for generating innovative ideas.
- Components of e-manufacturing technology are reviewed, including CAD/CAM, CNC machines, and e-procurement.
201201 ureason introduction to use
General introductionto USE - UReason Solution Environment (USE). For more information visit http://www.ureason.com
Lab Optimizer
The document describes BearingPoint's LAB Optimizer accelerator which helps laboratories connect lean processes with digital technologies. It provides an end-to-end approach along the laboratory value chain from planning and sample management to test data processing and certificate creation. This allows laboratories to unlock their potential and achieve cost efficiency, compliance and transparency. The approach involves aligning business processes with digital tools like automation, master data systems and digital workflows. This provides an efficient modern laboratory environment.
Sistel Control Profile [EN]
Sistel Control is a system integration company with 19 years of experience in automation projects for the life science sector. It has 25 employees across offices in Barcelona, Madrid, and Bordeaux. The company has completed over 500 automation projects in 14 countries for pharmaceutical and biotech clients. It offers services including control engineering, project implementation, customer support, and infrastructure monitoring to meet client needs.
Automating Clinical Trials in Pharmacology Units
Electronic Data Capture (EDC) is now the preferred technology which provides significant benefits over traditional, manual data entry methods. In a recent guidance (Sept 2013) the FDA promotes capturing source data in electronic form, ensuring the reliability, quality, integrity, and traceability of data from electronic source all the way through to electronic regulatory submission.
The adoption of an eSource system to run a clinical pharmacology unit goes beyond simple EDC, it is about complete clinic automation. In this presentation we will share implementation experiences, benefits, and lessons learned while replacing paper source at the clinical unit through embedding eSource in all operational processes, from set-up of the eSource to delivery of SDTM compliant datasets.
Updated October 2014 with new figures.
Architecting Design Development Test Request System in Aras
Presenter: Isaiah Kincaid, Carlisle Brake & Friction
Find out how a test request driven system was implemented in Aras for iterative design & development of parts and formulations. Learn how integrating test requests, parts, projects, procedures, scripts, equipment, calibration, preventative maintenance, raw data, and reports was essential to business operations worldwide.
PPM Implementation Kick-Off PBC
The document discusses an agenda for a PPM implementation kick-off meeting. It includes introductions of roles, terminology definitions for PPM, PLM, COLA, etc. It provides background on the partner organizations involved and what PPM and PLM are. It demonstrates the PPM software capabilities like project templates, timelines, dashboards. It discusses challenges at Pabst like multiple data sources and establishing a single source of truth. It outlines a phased PPM/PLM implementation approach to prioritize challenges like GPI management and project portfolio management.
Plab system owners meeting v2
Kingshuk Dasgupta leads pLab, which helps institutionalize performance engineering across the enterprise. pLab aims to promote performance awareness, educate teams, benchmark technologies, and build a shared testing environment. Performance is defined as a system's ability to meet objectives for response time, stability, scalability, and efficiency. Issues caused by poor performance include increased costs and lost income/competitiveness. pLab monitors key metrics like response times and outages to ensure service level targets are met.
Software Testing Competencies - Rishabh Software
The document discusses a Quality Assurance Test Centre (QATC) that provides testing services to empower businesses. The QATC uses a shared services model with standardized processes, tools, and metrics to efficiently deliver high quality testing. It offers a portfolio of services including independent testing, test automation, performance testing, and process consultation. Engagements follow a defined methodology leveraging the QATC's expertise in automation tools and proven frameworks. Benefits include reduced costs, improved quality, and ensuring business requirements are met. A case study highlights how the QATC tested a tax filing system for a large client.
Similar to Lonza Moda Solution Overview 2010 Final 18 Aug2010 (20)
An Enterprise Approach to Engine Test Analysis: Requirements for Implementation
An Enterprise Approach to Engine Test Analysis: Requirements for Implementation
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Architecting Design Development Test Request System in Aras
Architecting Design Development Test Request System in Aras
Lonza Moda Solution Overview 2010 Final 18 Aug2010
- 1. MODA™ Solution Overview x Rapid Testing Solutions / Lonza / 10 August 2010
- 3. Lonza’s Life-Science Platform Custom Manufacturing Nutrition Ingredients Microbial Control Performance Intermediates Therapeutic Cell Solutions Rapid Testing Solutions Research Solutions Chemical Manufacturing Biological Manufacturing Development Services Life Science Ingredients Bioscience MODA™ Solution Endotoxin Detection Microbiology Informatics Solutions Support
- 6. The Solution Improved Compliance Increased Productivity Expedited Decision Making Paperless, Automated Laboratory MODA ™ Solution Components Mobile Data Acquisition Flexible Workflow Integration On-Demand Analytics Systems (ERP, LIMS, CAPA) Devices Media
- 9. “ Go Green” with MODA™ Solution
- 10. MODA™ Solution: Components MODA-EM™ Client Software to manage the entire lifecycle of EM samples without paper MODA-FDC™ Mobile Field Data Capture platform for sampling in all critical areas MODA-EM™ Server Database to store, administer, and report all EM data MODA-VIP™ Visual Intelligence Portal, advanced visualization of EM data
- 12. Comparison: QC Micro Processes (MODA™ Solution) Rapid Testing Solutions / Lonza
- 13. The Paper-based QC Process Example: EM Sampling and Lab Processing Print sampling schedule & labels per EM SOP Reconcile planned samples with collected samples Close out sampling schedule per EM SOP Put on sterile outer garments and enter processing area Identify area to collect samples from facility map Collect sample and affix label Record date, time and initials on paper schedule and media Record sample receipt Prepare samples for testing. Report media lot, equipment, dilution info Record incubation start date and time Incubate samples Record incubation stop date and time Analyze samples and record results Aggregate data Trend results Report results Investigate excursion Trends OK? NO All samples collected All samples accounted for? Deliver sampling paperwork to QC Supervisor Assign sampling activities to QC Analysts NO YES NO Deliver samples to Microbiology or Biochemistry for processing YES NO Results in range? Notification of Alert or Action YES YES
- 14. The Paperless QC Process— 11 Steps Removed Example: EM Sampling and Lab Processing Print sampling schedule & labels per EM SOP Reconcile planned samples with collected samples Close out sampling schedule per EM SOP Put on sterile outer garments and enter processing area Identify area to collect samples from facility map Collect sample and affix label Record date, time and initials on paper schedule and media Record sample receipt Prepare samples for testing. Report media lot, equipment, dilution info Record incubation start date and time Incubate samples Record incubation stop date and time Analyze samples and record results Aggregate data Trend results Report results Investigate excursion Trends OK? NO All samples collected All samples accounted for? Deliver sampling paperwork to QC Supervisor Assign sampling activities to QC Analysts NO YES NO Deliver samples to Microbiology or Biochemistry for processing YES NO Results in range? Notification of Alert or Action YES YES
- 15. Paperless Efficiency Example Paper 8 hours – Paperless 4 Hours = Savings 4 Hours
- 16. The Paper-based QC Process Example: Non-Viable Air Testing
- 17. The Paperless Process Example: Non-Viable Air Testing
- 18. Automated Reporting and Analytics
- 19. Demonstration (MODA™ Solution) Rapid Testing Solutions / Lonza